Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MDAI
MDAI logo

MDAI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Spectral AI Inc (MDAI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.310
1 Day change
2.67%
52 Week Range
3.210
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Spectral AI Inc (MDAI) is not a strong buy for a beginner, long-term investor at this time. The lack of positive financial performance, no recent news catalysts, and neutral trading sentiment do not support an immediate investment decision. The technical indicators are neutral, and there are no strong proprietary trading signals to suggest a compelling entry point.

Technical Analysis

The MACD histogram is positive but contracting, RSI is neutral at 49.23, and moving averages are converging, indicating no clear trend. Support is at 1.722, resistance at 1.99. The stock has an 80% chance to rise 3.9% in the next day and 5.79% in the next week, but a potential decline of -1.02% in the next month.

Positive Catalysts

  • Gross margin increased by 2.61% YoY, indicating slight operational efficiency improvement.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from hedge funds or insiders.

Financial Performance

In Q4 2025, the company experienced significant declines in revenue (-46.27%), net income (-113.59%), and EPS (-107.69%). However, gross margin improved slightly to 45.18%, up 2.61% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes available for this stock.

Wall Street analysts forecast MDAI stock price to rise
2 Analyst Rating
Wall Street analysts forecast MDAI stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.250
sliders
Low
3
Averages
4.5
High
6
Current: 2.250
sliders
Low
3
Averages
4.5
High
6
BTIG
Buy
downgrade
$3 -> $2
AI Analysis
2025-05-14
Reason
BTIG
Price Target
$3 -> $2
AI Analysis
2025-05-14
downgrade
Buy
Reason
BTIG lowered the firm's price target on Spectral AI to $2 from $3 and keeps a Buy rating on the shares after its Q1 results. The company is appropriately trimming operating spend to preserve cash, though the firm is reducing its price target to reflect a higher share count, the analyst tells investors in a research note. Spectral AI also continues to expect to submit DeepView to the FDA by the end of 2Q25 with approval expected in early FY26, the firm adds.

People Also Watch